| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An innovative housing-related measure for individual socioeconomic status and human papillomavirus vaccination coverage: A population-based cross-sectional study
|
MacLaughlin, Kathy L.
|
|
|
38 |
39 |
p. 6112-6119
|
artikel
|
| 2 |
A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection
|
Zhang, Teng
|
|
|
38 |
39 |
p. 6153-6161
|
artikel
|
| 3 |
Assessment of VaxTrac electronic immunization registry in an urban district in Sierra Leone: Implications for data quality, defaulter tracking, and policy
|
Jalloh, Mohamed F.
|
|
|
38 |
39 |
p. 6103-6111
|
artikel
|
| 4 |
Combining cluster surveys to estimate vaccination coverage: Experiences from Nigeria’s multiple indicator cluster survey / national immunization coverage survey (MICS/NICS), 2016–17
|
Rhoda, Dale A.
|
|
|
38 |
39 |
p. 6174-6183
|
artikel
|
| 5 |
Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages
|
Chen, Qi
|
|
|
38 |
39 |
p. 6096-6102
|
artikel
|
| 6 |
Costs and effectiveness of alternative dog vaccination strategies to improve dog population coverage in rural and urban settings during a rabies outbreak
|
Undurraga, Eduardo A.
|
|
|
38 |
39 |
p. 6162-6173
|
artikel
|
| 7 |
Design and content validation of a survey questionnaire assessing the determinants of human papillomavirus (HPV) vaccine hesitancy in France: A reactive Delphi study
|
Dib, Fadia
|
|
|
38 |
39 |
p. 6127-6140
|
artikel
|
| 8 |
Editorial Board/Aims and Scope
|
|
|
|
38 |
39 |
p. IFC
|
artikel
|
| 9 |
Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines
|
Forman, Rebecca
|
|
|
38 |
39 |
p. 6075-6077
|
artikel
|
| 10 |
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
|
Verdijk, Pauline
|
|
|
38 |
39 |
p. 6088-6095
|
artikel
|
| 11 |
Immunogenicity and protective efficacy of clade 2.3.2.1c and clade 2.3.4.4c H5Nx avian influenza antigen bank vaccines in mice, Korea
|
Kim, Hyun-Mi
|
|
|
38 |
39 |
p. 6080-6087
|
artikel
|
| 12 |
Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
|
Kim, Yun-Hee
|
|
|
38 |
39 |
p. 6141-6152
|
artikel
|
| 13 |
Influenza immunization and COVID-19
|
Maltezou, Helena C.
|
|
|
38 |
39 |
p. 6078-6079
|
artikel
|
| 14 |
Influenza vaccination among U.S. pediatric patients receiving care from federally funded health centers
|
Lebrun-Harris, Lydie A.
|
|
|
38 |
39 |
p. 6120-6126
|
artikel
|
| 15 |
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines
|
Kochhar, Sonali
|
|
|
38 |
39 |
p. 6184-6189
|
artikel
|
Tijdschrift beschrijving